Yaliang Zhang

995 total citations · 1 hit paper
29 papers, 708 citations indexed

About

Yaliang Zhang is a scholar working on Molecular Biology, Organic Chemistry and Computational Theory and Mathematics. According to data from OpenAlex, Yaliang Zhang has authored 29 papers receiving a total of 708 indexed citations (citations by other indexed papers that have themselves been cited), including 19 papers in Molecular Biology, 15 papers in Organic Chemistry and 4 papers in Computational Theory and Mathematics. Recurrent topics in Yaliang Zhang's work include Synthesis and biological activity (14 papers), Click Chemistry and Applications (8 papers) and Cancer therapeutics and mechanisms (6 papers). Yaliang Zhang is often cited by papers focused on Synthesis and biological activity (14 papers), Click Chemistry and Applications (8 papers) and Cancer therapeutics and mechanisms (6 papers). Yaliang Zhang collaborates with scholars based in China, Czechia and United States. Yaliang Zhang's co-authors include Hai‐Liang Zhu, Yajuan Qin, Yanting Wang, Chao Yan, Tengfei Huang, Tianqi Xu, Yuyuan Dai, Yangfan Wang, Zhong‐Chang Wang and Zhiyuan Wang and has published in prestigious journals such as Journal of Biological Chemistry, Molecules and Statistics in Medicine.

In The Last Decade

Yaliang Zhang

26 papers receiving 701 citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Cannabidiol inhibits human glioma by induction of lethal mitophagy through activating TRPV4

2021 154 citations Tengfei Huang, Tianqi Xu et al. Autophagy profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Yaliang Zhang China	15	350	323	79	64	61	29	708
Xianling Ning China	13	169 0.5×	374 1.2×	57 0.7×	168 2.6×	70 1.1×	29	607
Tony Eight Lin Taiwan	18	175 0.5×	644 2.0×	109 1.4×	45 0.7×	220 3.6×	60	881
Ingo V. Hartung Germany	14	477 1.4×	315 1.0×	53 0.7×	56 0.9×	70 1.1×	36	906
Steve Perry United States	13	112 0.3×	337 1.0×	124 1.6×	120 1.9×	34 0.6×	18	737
Yongqi Zhen China	15	107 0.3×	400 1.2×	66 0.8×	61 1.0×	106 1.7×	30	691
Jiyue Zheng China	18	349 1.0×	411 1.3×	59 0.7×	62 1.0×	154 2.5×	39	910
Irida Kastrati United States	14	176 0.5×	376 1.2×	42 0.5×	144 2.3×	203 3.3×	35	771
John Herich United States	7	304 0.9×	304 0.9×	171 2.2×	41 0.6×	59 1.0×	7	799
Efrosini Barbayianni Greece	16	152 0.4×	470 1.5×	62 0.8×	39 0.6×	36 0.6×	25	659
Isak Im South Korea	12	147 0.4×	295 0.9×	44 0.6×	19 0.3×	55 0.9×	16	534

Countries citing papers authored by Yaliang Zhang

Since Specialization

Citations

This map shows the geographic impact of Yaliang Zhang's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Yaliang Zhang with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Yaliang Zhang more than expected).

Fields of papers citing papers by Yaliang Zhang

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Yaliang Zhang. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Yaliang Zhang. The network helps show where Yaliang Zhang may publish in the future.

Co-authorship network of co-authors of Yaliang Zhang

This figure shows the co-authorship network connecting the top 25 collaborators of Yaliang Zhang. A scholar is included among the top collaborators of Yaliang Zhang based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Yaliang Zhang. Yaliang Zhang is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Zhang, Yixuan, Weiyi Zhang, Rongjie Cheng, et al.. (2025). RASON promotes KRASG12C-driven tumor progression and immune evasion in non-small cell lung cancer. Journal of Experimental & Clinical Cancer Research. 44(1). 106–106. 1 indexed citations

Zhang, Yaliang, et al.. (2025). BCI inhibits MKP3 by targeting the kinase-binding domain and disrupting ERK2 interaction. Journal of Biological Chemistry. 301(9). 110570–110570.

Xu, Tianqi, et al.. (2025). Discovery of novel thiazolylhydrazone derivatives as potent anti-cancer agents inducing ferroptosis via direct NRF2 inhibition. European Journal of Medicinal Chemistry. 297. 117912–117912.

Cheng, Rongjie, Fanying Li, Maolei Zhang, et al.. (2022). A novel protein RASON encoded by a lncRNA controls oncogenic RAS signaling in KRAS mutant cancers. Cell Research. 33(1). 30–45. 40 indexed citations

Zhang, Yang, Yiran Li, Yaliang Zhang, et al.. (2022). Mannose‐targeting Concanavalin A−Epirubicin Conjugate for Targeted Intravesical Chemotherapy of Bladder Cancer. Chemistry - An Asian Journal. 17(16). e202200342–e202200342. 16 indexed citations

Huang, Tengfei, Tianqi Xu, Yangfan Wang, et al.. (2021). Cannabidiol inhibits human glioma by induction of lethal mitophagy through activating TRPV4. Autophagy. 17(11). 3592–3606. 154 indexed citations breakdown →

Wang, Ruimin, Yunlong Wang, Xueying Zhang, et al.. (2019). Hierarchical cooperation of transcription factors from integration analysis of DNA sequences, ChIP-Seq and ChIA-PET data. BMC Genomics. 20(S3). 296–296. 9 indexed citations

Zhang, Yaliang, et al.. (2019). Tubulin Inhibitors Binding to Colchicine-Site: A Review from 2015 to 2019. Current Medicinal Chemistry. 27(40). 6787–6814. 42 indexed citations

Zhang, Yaliang, et al.. (2019). Synthesis, anticancer activity and molecular docking studies on 1,2-diarylbenzimidazole analogues as anti-tubulin agents. Bioorganic Chemistry. 92. 103219–103219. 16 indexed citations

10.

Wei, Jiali, Qing Zhang, Yaliang Zhang, et al.. (2018). Pharmacodynamic and pharmacokinetic characteristics of YMR-65, a tubulin inhibitor, in tumor-bearing mice. European Journal of Pharmaceutical Sciences. 121. 74–84. 11 indexed citations

11.

Zhang, Yaliang, et al.. (2018). A class of novel tubulin polymerization inhibitors exert effective anti-tumor activity via mitotic catastrophe. European Journal of Medicinal Chemistry. 163. 896–910. 33 indexed citations

12.

Chen, Kun, Yaliang Zhang, Jing Fan, et al.. (2018). Novel nicotinoyl pyrazoline derivates bearing N-methyl indole moiety as antitumor agents: Design, synthesis and evaluation. European Journal of Medicinal Chemistry. 156. 722–737. 46 indexed citations

13.

Cai, Xunchao, et al.. (2016). Synthesis, molecular docking and biological evaluation of 1‐phenylsulphonyl‐2‐(1‐methylindol‐3‐yl)‐benzimidazole derivatives as novel potential tubulin assembling inhibitors. Chemical Biology & Drug Design. 90(1). 112–118. 10 indexed citations

14.

Zhang, Yaliang, Yajuan Qin, Boyan Li, et al.. (2016). Synthesis and Biological Evaluation of 1‐Methyl‐1H‐indole–Pyrazoline Hybrids as Potential Tubulin Polymerization Inhibitors. ChemMedChem. 11(13). 1446–1458. 40 indexed citations

15.

Wang, Yanting, Yajuan Qin, Na Yang, et al.. (2015). Synthesis, biological evaluation, and molecular docking studies of novel 1-benzene acyl-2-(1-methylindol-3-yl)-benzimidazole derivatives as potential tubulin polymerization inhibitors. European Journal of Medicinal Chemistry. 99. 125–137. 51 indexed citations

16.

Yin, Yong, Yaliang Zhang, Mengyue Zhao, et al.. (2015). Synthesis, biological evaluation and 3D-QSAR studies of novel 5-phenyl-1H-pyrazol cinnamamide derivatives as novel antitubulin agents. European Journal of Medicinal Chemistry. 93. 291–299. 26 indexed citations

17.

Wang, Yanting, Yajuan Qin, Yaliang Zhang, et al.. (2014). Synthesis, biological evaluation, and molecular docking studies of novel chalcone oxime derivatives as potential tubulin polymerization inhibitors. RSC Advances. 4(61). 32263–32275. 13 indexed citations

18.

Li, Yujing, Yajuan Qin, Jigar A. Makawana, et al.. (2014). Synthesis, biological evaluation and molecular modeling of 1,3,4-thiadiazol-2-amide derivatives as novel antitubulin agents. Bioorganic & Medicinal Chemistry. 22(15). 4312–4322. 22 indexed citations

19.

Qin, Yajuan, Man Xing, Yaliang Zhang, et al.. (2014). Design, synthesis and biological evaluation of (1,3-diphenyl-1H-pyrazol-4-yl) methyl benzoate derivatives as potential BRAF^V600E inhibitors. RSC Advances. 4(95). 52702–52711. 13 indexed citations

20.

Zhu, Yinling, Pingting Zhu, Jigar A. Makawana, et al.. (2014). Design, synthesis and biological evaluation of novel 5-phenyl-1H-pyrazole derivatives as potential BRAFV600E inhibitors. Bioorganic & Medicinal Chemistry. 22(21). 6201–6208. 29 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact